State Street’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.8M | Sell |
1,554,431
-206,276
| -12% | -$9M | ﹤0.01% | 1522 |
|
|
2025
Q1 | $48.2M | Buy |
1,760,707
+71,918
| +4% | +$1.97M | ﹤0.01% | 1665 |
|
|
2024
Q4 | $67.9M | Sell |
1,688,789
-39,355
| -2% | -$1.58M | ﹤0.01% | 1559 |
|
|
2024
Q3 | $81.8M | Sell |
1,728,144
-182,547
| -10% | -$8.64M | ﹤0.01% | 1448 |
|
|
2024
Q2 | $57M | Sell |
1,910,691
-761,827
| -29% | -$22.7M | ﹤0.01% | 1606 |
|
|
2024
Q1 | $107M | Buy |
2,672,518
+778,239
| +41% | +$31.3M | ﹤0.01% | 1265 |
|
|
2023
Q4 | $48.2M | Sell |
1,894,279
-91,607
| -5% | -$2.33M | ﹤0.01% | 1721 |
|
|
2023
Q3 | $27.6M | Sell |
1,985,886
-634,423
| -24% | -$8.82M | ﹤0.01% | 1978 |
|
|
2023
Q2 | $60.2M | Sell |
2,620,309
-106,516
| -4% | -$2.45M | ﹤0.01% | 1550 |
|
|
2023
Q1 | $80.8M | Sell |
2,726,825
-119,396
| -4% | -$3.54M | ﹤0.01% | 1326 |
|
|
2022
Q4 | $71M | Buy |
2,846,221
+160,817
| +6% | +$4.01M | ﹤0.01% | 1404 |
|
|
2022
Q3 | $58.5M | Sell |
2,685,404
-829,034
| -24% | -$18M | ﹤0.01% | 1492 |
|
|
2022
Q2 | $69.2M | Buy |
3,514,438
+1,419,877
| +68% | +$28M | ﹤0.01% | 1419 |
|
|
2022
Q1 | $88.6M | Buy |
2,094,561
+452,799
| +28% | +$19.2M | ﹤0.01% | 1379 |
|
|
2021
Q4 | $104M | Buy |
1,641,762
+201,986
| +14% | +$12.8M | ﹤0.01% | 1267 |
|
|
2021
Q3 | $84.6M | Buy |
1,439,776
+103,130
| +8% | +$6.06M | ﹤0.01% | 1409 |
|
|
2021
Q2 | $64.8M | Buy |
1,336,646
+399,731
| +43% | +$19.4M | ﹤0.01% | 1656 |
|
|
2021
Q1 | $36.4M | Buy |
936,915
+776,370
| +484% | +$30.2M | ﹤0.01% | 1971 |
|
|
2020
Q4 | $9.95M | Buy |
+160,545
| New | +$9.95M | ﹤0.01% | 2631 |
|